tiprankstipranks
Advertisement
Advertisement

AMGN Stock Latest News

Amgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market
Company AnnouncementsAmgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market
9h ago
AMGN
Amgen price target raised to $340 from $332 at Morgan Stanley
PremiumThe Fly
Amgen price target raised to $340 from $332 at Morgan Stanley
2d ago
AMGN
Climb Bio initiated with a Buy at Guggenheim
PremiumThe Fly
Climb Bio initiated with a Buy at Guggenheim
4d ago
AMGN
CLYM
Amgen announces data at ADA Scientific Sessions on cardiometabolic conditions
PremiumThe Fly
Amgen announces data at ADA Scientific Sessions on cardiometabolic conditions
4d ago
AMGN
Amgen price target lowered to $389 from $425 at Goldman Sachs
PremiumThe Fly
Amgen price target lowered to $389 from $425 at Goldman Sachs
7d ago
AMGN
European Commission approves Amgen’s Imdylltra for ES-SCLC
PremiumThe FlyEuropean Commission approves Amgen’s Imdylltra for ES-SCLC
10d ago
AMGN
Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study
Premium
Company Announcements
Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study
20d ago
AMGN
Amgen Shareholders Reaffirm Board, Pay and Auditors
Premium
Company Announcements
Amgen Shareholders Reaffirm Board, Pay and Auditors
22d ago
8K
AMGN
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer
PremiumCompany Announcements
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer
22d ago
AMGN
Amgen Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
Amgen Earnings Call Highlights Growth Amid Headwinds
23d ago
AMGN
Amgen Announces CFO Transition and Leadership Succession Plan
PremiumCompany Announcements
Amgen Announces CFO Transition and Leadership Succession Plan
23d ago
8K
AMGN
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed
PremiumThe Fly
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed
23d ago
AMGN
Amgen price target lowered to $427 from $432 at Piper Sandler
PremiumThe FlyAmgen price target lowered to $427 from $432 at Piper Sandler
29d ago
AMGN
The Week That Was, The Week Ahead: Macro and Markets, May 10
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, May 10
1M ago
F
V
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
Premium
Market News
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
1M ago
BLK
IBB
Honeywell-Backed Quantinuum Files for IPO amid Quantum Computing Excitement
PremiumMarket News
Honeywell-Backed Quantinuum Files for IPO amid Quantum Computing Excitement
1M ago
HON
AMGN
Amgen Halts Phase 2 HZN-1116 Trial in Sjögren’s: What Investors Should Know
PremiumCompany Announcements
Amgen Halts Phase 2 HZN-1116 Trial in Sjögren’s: What Investors Should Know
1M ago
AMGN
Amgen upgraded to Buy from Hold at Freedom Broker
PremiumThe Fly
Amgen upgraded to Buy from Hold at Freedom Broker
1M ago
AMGN
Amgen downgraded to Hold from Buy at Erste Group
PremiumThe Fly
Amgen downgraded to Hold from Buy at Erste Group
1M ago
AMGN
Erste downgrades Amgen on declining sales growth
PremiumThe FlyErste downgrades Amgen on declining sales growth
1M ago
AMGN
Amgen to invest additional $300M in U.S. manufacturing network
Premium
The Fly
Amgen to invest additional $300M in U.S. manufacturing network
1M ago
AMGN
Amgen price target lowered to $340 from $351 at Guggenheim
Premium
The Fly
Amgen price target lowered to $340 from $351 at Guggenheim
1M ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >